|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
|
ZA927277B
(en)
*
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
DK0642332T3
(da)
|
1992-05-13 |
1997-06-16 |
Sandoz Ltd |
Ophthalmiske præparater indeholdende cyclosporin
|
|
US5830508A
(en)
|
1992-08-06 |
1998-11-03 |
Deo Corporation |
Composition for treating dry eye
|
|
US5366739A
(en)
*
|
1992-08-06 |
1994-11-22 |
Deo Corporation |
Method of ophthalmic drug delivery
|
|
US5686436A
(en)
|
1993-05-13 |
1997-11-11 |
Hiv Diagnostics, Inc. |
Multi-faceted method to repress reproduction of latent viruses in humans and animals
|
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
|
IE75744B1
(en)
*
|
1995-04-03 |
1997-09-24 |
Elan Corp Plc |
Controlled release biodegradable micro- and nanospheres containing cyclosporin
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
ES2169351T3
(es)
|
1996-02-13 |
2002-07-01 |
Searle & Co |
Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa.
|
|
EP0880363B1
(en)
*
|
1996-02-13 |
2002-09-11 |
G.D. SEARLE & CO. |
Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
|
|
CA2238029A1
(en)
*
|
1996-03-05 |
1997-09-12 |
Medinox, Inc. |
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
|
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
|
DE69840586D1
(de)
|
1997-10-08 |
2009-04-02 |
Isotechnika Inc |
Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
|
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
|
US5981607A
(en)
*
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
GB9818278D0
(en)
*
|
1998-08-22 |
1998-10-14 |
Smith & Nephew |
Compositions
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
|
US6255280B1
(en)
|
1999-04-08 |
2001-07-03 |
University Of Kentucky Research Foundation |
Protection against traumatic brain injury
|
|
US6254860B1
(en)
*
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
|
CN1268623C
(zh)
*
|
1999-10-15 |
2006-08-09 |
苏坎波公司 |
组合物和使该组合物稳定的方法
|
|
EP1142566B1
(fr)
|
2000-04-07 |
2003-10-01 |
Laboratoire Medidom S.A. |
Formulations ophtalmiques à base de ciclosporine, d'acide hyaluronique et du polysorbate
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
WO2002098376A1
(en)
*
|
2001-06-06 |
2002-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enyzmes
|
|
SI1436321T1
(sl)
*
|
2001-10-19 |
2006-12-31 |
Isotechnika Inc |
Sinteza analogov ciklosporina
|
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
US6930127B2
(en)
*
|
2002-08-15 |
2005-08-16 |
Eaton Veterinary Laboratories, Inc. |
Veterinary treatment of ophthalmic disease in animals using topical tacrolimus
|
|
US7354574B2
(en)
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7538084B2
(en)
*
|
2003-03-17 |
2009-05-26 |
Amr Technology, Inc. |
Cyclosporins
|
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
|
EP1608347B1
(en)
*
|
2003-03-28 |
2014-08-13 |
Sigmoid Pharma Limited |
Solid oral dosage form containing seamless microcapsules
|
|
US7083802B2
(en)
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US20050059583A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
|
CN102144961A
(zh)
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
CN100548271C
(zh)
|
2004-01-20 |
2009-10-14 |
阿勒根公司 |
用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
|
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
|
US20050277584A1
(en)
*
|
2004-06-09 |
2005-12-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
|
EP1811979B1
(en)
*
|
2004-09-27 |
2008-11-05 |
Sigmoid Pharma Limited |
Microcapsules comprising a methylxanthine and a corticosteroid
|
|
US7511013B2
(en)
*
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
|
US7378391B2
(en)
*
|
2004-09-29 |
2008-05-27 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
|
EP1812037A4
(en)
*
|
2004-10-06 |
2009-11-11 |
Amr Technology Inc |
ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
|
|
US7151085B2
(en)
*
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
|
WO2006073786A2
(en)
*
|
2004-12-30 |
2006-07-13 |
Bausch & Lomb Incorporated |
Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
|
CA2615990A1
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
|
EP3103468B1
(en)
*
|
2005-10-14 |
2020-07-15 |
Allergan, Inc. |
Prevention of drug-associated keratoconjunctivitis with a cyclosporin
|
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
|
US20070225217A1
(en)
|
2005-11-09 |
2007-09-27 |
Combinatorx, Incorporated |
Methods, compositions, and kits for the treatment of medical conditions
|
|
BRPI0707612B8
(pt)
|
2006-02-09 |
2021-05-25 |
Macusight Inc |
vaso lacrado e formulações líquidas contidas no mesmo
|
|
US7655625B2
(en)
*
|
2006-02-13 |
2010-02-02 |
Allergan, Inc. |
Methods of treating blepharospasm using cyclosporine components
|
|
US7557082B2
(en)
|
2006-03-03 |
2009-07-07 |
Allergan, Inc. |
Treatment with cyclosporin A
|
|
US20070219127A1
(en)
*
|
2006-03-20 |
2007-09-20 |
Walt John G |
Cyclosporin a compositions
|
|
WO2007112052A2
(en)
|
2006-03-23 |
2007-10-04 |
Macusight, Inc. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
|
US20080146497A1
(en)
*
|
2006-07-25 |
2008-06-19 |
Graham Richard S |
Cyclosporin Compositions
|
|
EP2061440A2
(en)
|
2007-04-04 |
2009-05-27 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
|
CA2686234A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Allergan, Inc. |
Use of cyclosporines in the treatment of patients with intraocular lenses
|
|
US20090081277A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Allergan, Inc. |
Pharmaceutical formulations and methods for treating ocular conditions
|
|
MX2010003364A
(es)
*
|
2007-10-08 |
2010-07-06 |
Lux Biosciences Inc |
Composiciones oftalmicas que comprenden inhibidores de calcineurina o inhibidores de mtor.
|
|
ITMI20080003A1
(it)
*
|
2008-01-02 |
2009-07-03 |
Alfredo Pulpito |
Composizioni per uso oftalmico
|
|
EP2310008A4
(en)
*
|
2008-07-09 |
2014-03-05 |
Aspreva Internat Ltd |
MYCOPHENOLIC SODIUM ACID SOLUTIONS WITH PH SPECIFIC FOR THE TREATMENT OF OCULAR DISORDERS
|
|
US9445975B2
(en)
*
|
2008-10-03 |
2016-09-20 |
Access Business Group International, Llc |
Composition and method for preparing stable unilamellar liposomal suspension
|
|
EA201190088A1
(ru)
|
2009-01-08 |
2012-02-28 |
Аллерган, Инк. |
Композиции циклоспорина для усиления роста ногтей
|
|
US20110009339A1
(en)
*
|
2009-04-14 |
2011-01-13 |
Allergan, Inc |
Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
|
|
JP5640079B2
(ja)
|
2009-05-18 |
2014-12-10 |
シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ |
油滴含有組成物
|
|
KR101778316B1
(ko)
|
2009-06-05 |
2017-09-13 |
알러간, 인코포레이티드 |
인공 눈물 및 치료학적 용도
|
|
WO2010144194A1
(en)
*
|
2009-06-09 |
2010-12-16 |
Lux Biosciences, Inc. |
Topical drug delivery systems for ophthalmic use
|
|
CN102573802A
(zh)
|
2009-08-12 |
2012-07-11 |
希格默伊德药业有限公司 |
包含聚合物基质和油相的免疫调节组合物
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
EP2515864A4
(en)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
DELAYED RELEASE DELIVERY DEVICES
|
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
|
US8957048B2
(en)
|
2011-10-06 |
2015-02-17 |
Allergan, Inc. |
Compositions for the treatment of dry eye
|
|
AU2012339695B2
(en)
|
2011-11-15 |
2017-10-05 |
Allergan, Inc. |
Sustained action formulation of cyclosporin Form 2
|
|
ES2666191T3
(es)
|
2011-11-15 |
2018-05-03 |
Allergan, Inc. |
Un proceso para la cristalización de la forma 2 de la ciclosporina A
|
|
JP6363506B2
(ja)
|
2011-11-15 |
2018-07-25 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
シクロスポリンａ２型の懸濁剤
|
|
US9907826B2
(en)
|
2011-12-07 |
2018-03-06 |
Allergan, Inc. |
Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
|
|
US20130266615A1
(en)
*
|
2012-04-10 |
2013-10-10 |
Bin Wu |
Non-immunogenic delivery vehicle for beta-, gamma-, and delta-tocopherols and methods of using and making same
|
|
WO2013158296A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Howard University |
Method of treating an ocular disease and compositions effective for treating an ocular disease
|
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
|
EP3215127B1
(en)
|
2014-11-07 |
2020-10-28 |
Sublimity Therapeutics Limited |
Compositions comprising cyclosporin
|
|
JP6768653B2
(ja)
|
2014-11-25 |
2020-10-14 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
安定したオメガ−３眼科用組成物
|
|
US9820954B2
(en)
|
2015-08-19 |
2017-11-21 |
Jenivision Inc. |
Quantitative peri-orbital application of ophthalmology drugs
|
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|